Statins activate endoplasmic reticulum stress via inhibition of RAS prenylation, leading to enhanced immune responses against KRAS-mutant cancer cell lines and against KRAS-mutant tumours in the lung and liver of genetically engineered mouse models (Nam et al., 2021). Here, KRAS is linked to cancer.